Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia
Pediatric Blood & Cancer · 2026-10 · 73 (10)
DOI: 10.1002/1545-5017.70552 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 23.07.2026. Verfasst von Te-Fu Weng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
ORCID-Profile: Te-Fu Weng, Kang-Hsi Wu
Zitieren
APA
Weng, T. F., & Wu, K. H. (2026). Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70552
Vancouver
Weng TF, Wu KH. Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70552
BibTeX
@article{Weng2026,
author = {Weng, Te-Fu and Wu, Kang-Hsi},
title = {Post‐Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {10},
doi = {10.1002/1545-5017.70552}
}
EUVIMED